Castleman’s Disease

  • Richard Flavin
  • Cara M. Martin
  • Orla Sheils
  • John James O’Leary
Part of the Molecular Pathology Library book series (MPLB, volume 4)


Castleman’s disease (CD) is a rare, benign lymphoproliferative disorder of lymph nodes that was first described by Dr. Benjamin Castleman in 1956. CD is also known as giant lymph node hyperplasia or angiofollicular hyperplasia.


Human Immunodeficiency Virus Poem Syndrome Polyclonal Hypergammaglobulinemia Giant Lymph Node Hyperplasia Hyperplastic Follicle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Weisenburger DD, Nathwani BN, Winberg CD, et al. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol. 1985;16(2):162–172.CrossRefPubMedGoogle Scholar
  2. 2.
    Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670–683.CrossRefPubMedGoogle Scholar
  3. 3.
    Gili A, Ngan BY, Lester R. Castleman’s disease associated with pemphigus vulgaris. J Am Acad Dermatol. 1991;25(5 pt 2):955–959.CrossRefPubMedGoogle Scholar
  4. 4.
    Ordi J, Grau JM, Junque A, et al. Secondary (AA) amyloidosis associated with Castleman’s disease. Report of two cases and review of the literature. Am J Clin Pathol. 1993;100(4):394–397.PubMedGoogle Scholar
  5. 5.
    Kirsch CF, Webb EM, Webb WR. Multicentric Castleman’s disease and POEMS syndrome: CT findings. J Thorac Imaging. 1997;12(1):75–77.CrossRefPubMedGoogle Scholar
  6. 6.
    Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128(8):657–662.PubMedGoogle Scholar
  7. 7.
    Frizzera G, Peterson BA, Bayrd ED, et al. A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3(9):1202–1216.PubMedGoogle Scholar
  8. 8.
    Kessler E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer. 1985;56(10):2446–2451.CrossRefPubMedGoogle Scholar
  9. 9.
    Stebbing J, Pantanowitz L, Dayyani F, et al. HIV-associated multicentric Castleman’s disease. Am J Hematol. 2008;83(6):498–503.CrossRefPubMedGoogle Scholar
  10. 10.
    Lachant NA, Sun NC, Leong LA, et al. Multicentric angiofollicular lymph node hyperplasia (Castleman’s disease) followed by Kaposi’s sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol. 1985;83(1):27–33.PubMedGoogle Scholar
  11. 11.
    Laurent C, Meggetto F, Brousset P. Human herpesvirus 8 infections in patients with immunodeficiencies. Hum Pathol. 2008;39(7):983–993.CrossRefPubMedGoogle Scholar
  12. 12.
    Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95(4):1406–1412.PubMedGoogle Scholar
  13. 13.
    Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99(7):2331–2336.CrossRefPubMedGoogle Scholar
  14. 14.
    Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman’s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996;10(1):61–67.CrossRefPubMedGoogle Scholar
  15. 15.
    Zietz C, Bogner JR, Goebel FD, et al. An unusual cluster of cases of Castleman’s disease during highly active antiretroviral therapy for AIDS. N Engl J Med. 1999;340(24):1923–1924.CrossRefPubMedGoogle Scholar
  16. 16.
    Mylona EE, Baraboutis IG, Lekakis LJ, et al. Multicentric Castleman’s disease in HIV infection: a systematic review of the literature. AIDS Rev. 2008;10(1):25–35.PubMedGoogle Scholar
  17. 17.
    Parez N, Bader-Meunier B, Roy CC, et al. Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr. 1999;158(8):631–637.CrossRefPubMedGoogle Scholar
  18. 18.
    Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. J Virol. 1999;73(5):4181–4187.PubMedGoogle Scholar
  19. 19.
    Staskus KA, Zhong W, Gebhard K, et al. Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol. 1997;71(1):715–719.PubMedGoogle Scholar
  20. 20.
    Menke DM, Chadbum A, Cesarman E, et al. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of Castleman disease at low risk for HIV infection. Am J Clin Pathol. 2002;117(2):268–275.PubMedGoogle Scholar
  21. 21.
    Parravicini C, Corbellino M, Paulli M, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman’s disease. Am J Pathol. 1997;151(6):1517–1522.PubMedGoogle Scholar
  22. 22.
    Tohda S, Murakami N, Nara N. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman’s disease and related diseases. Int J Mol Med. 2001;8(5):549–551.PubMedGoogle Scholar
  23. 23.
    Brandt SJ, Bodine DM, Dunbar CE, et al. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice. J Clin Invest. 1990;86(2):592–599.CrossRefPubMedGoogle Scholar
  24. 24.
    Maslovsky I, Uriev L, Lugassy G. The heterogeneity of Castleman disease: report of five cases and review of the literature. Am J Med Sci. 2000;320(4):292-295.CrossRefPubMedGoogle Scholar
  25. 25.
    Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman’s disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994;330(9):602–605.CrossRefPubMedGoogle Scholar
  26. 26.
    Hsu SM, Waldron JA, Xie SS, et al. Expression of interleukin-6 in Castleman’s disease. Hum Pathol. 1993;24(8):833–839.CrossRefPubMedGoogle Scholar
  27. 27.
    Leger-Ravet MB, Peuchmaur M, Devergne O, et al. Interleukin-6 gene expression in Castleman’s disease. Blood. 1991;78(11):2923–2930.PubMedGoogle Scholar
  28. 28.
    Lotz M. Interleukin-6. Cancer Invest. 1993;11(6):732–742.CrossRefPubMedGoogle Scholar
  29. 29.
    Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood. 1989;74(4):1360–1367.PubMedGoogle Scholar
  30. 30.
    Barrie JR, English JC, Muller N. Castleman’s disease of the lung: radiographic, high-resolution CT, and pathologic findings. AJR Am J Roentgenol. 1996;166(5):1055–1056.PubMedGoogle Scholar
  31. 31.
    Newlon JL, Couch M, Brennan J. Castleman’s disease: three case reports and a review of the literature. Ear Nose Throat J. 2007;86(7):414–418.PubMedGoogle Scholar
  32. 32.
    Pavlidis NA, Skopouli FN, Bai MC, et al. A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman’s disease). Med Pediatr Oncol. 1990;18(4):333–335.CrossRefPubMedGoogle Scholar
  33. 33.
    Lanzafame M, Carretta G, Trevenzoli M, et al. Successful treatment of Castleman’s disease with HAART in two HIV-infected patients. J Infect. 2000;40(1):90–91.CrossRefPubMedGoogle Scholar
  34. 34.
    Pastor MA, Vasco B, Mosquera JM, et al. Two HHV8-related illnesses in a HIV-negative patient: Kaposi’s sarcoma and multicentric Castleman’s disease. Response to treatment with Rituximab and CHOP. Actas Dermosifiliogr. 2006;97(6):385–390.CrossRefPubMedGoogle Scholar
  35. 35.
    Adachi Y, Yoshio-Hoshino N, Nishimoto N. The blockade of IL-6 signaling in rational drug design. Curr Pharm Des. 2008;14(12):1217–1224.CrossRefPubMedGoogle Scholar
  36. 36.
    Ding C, Jones G. Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases. Rev Recent Clin Trials. 2006;1(3):193–200.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Richard Flavin
    • 1
  • Cara M. Martin
    • 2
  • Orla Sheils
    • 3
  • John James O’Leary
    • 4
  1. 1.Department of HistopathologyTrinity College DublinDublinIreland
  2. 2.Department of HistopathologyThe Coombe Women and Infant’s University Hospital, University of Dublin, Trinity CollegeDublinIreland
  3. 3.Department of Histopathology and Morbid AnatomyTrinity College DublinDublinIreland
  4. 4.Department of PathologyTrinity College DublinDublinIreland

Personalised recommendations